Retinopathy of Prematurity (ROP) Active Not Recruiting Phase 3 Trials for Aflibercept (DB08885)

Also known as: ROP - Retinopathy of Prematurity / Retinopathy of Prematurity / Retrolental fibroplasia / Retinopathy of prematurity (disorder) / Retinopathy of prematurity NOS / Retrolental fibroplasia (disorder)

IndicationStatusPhase
DBCOND0046296 (Retinopathy of Prematurity (ROP))Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04015180Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090Other
NCT04101721Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of PrematurityTreatment